UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000052929
Receipt number R000060389
Scientific Title CSFMAP
Date of disclosure of the study information 2023/11/28
Last modified on 2023/11/28 11:17:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Cerebrospinal fluid dynamics visualization study using MRI

Acronym

CSFMAP

Scientific Title

CSFMAP

Scientific Title:Acronym

CSFMAP

Region

Japan North America


Condition

Condition

Patients with hydrocephalus, syringomyelia, or arachnoid cysts who are attending or being admitted to facilities participating in this study, including the Department of Neurosurgery, Juntendo University Hospital, and those with normal spinal fluid circulation with headache, unruptured cerebral aneurysm, minor head injury, or minor stroke will be included.

Classification by specialty

Radiology Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Cerebrospinal fluid (CSF) is believed to protect the brain from external forces, but we do not know its detailed fluid dynamics. The purpose of this clinical study is to investigate the causes of hydrocephalus, syringomyelia, and arachnoid cysts, which are believed to be caused by abnormalities in cerebrospinal fluid (CSF), and to select the most appropriate treatment for these diseases. The purpose of this project is to advance in silico analysis of the biological turbulence of CSF that can occur in minor traumatic injuries. We will also analyze the dynamics and physiology of CSF flow as it is altered by external force factors, and examine the causes of traumatic brain injury (TBI).

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To investigate the causes of these diseases, MRI scans will be performed on patients with normal and those with CSF circulation disorders to collect information on CSF physiology. We will analyze CSF circulation information in each region of the cerebrospinal cord cavity using MRI in patients with normal and in patients with CSF circulation disorders by applying the improved time-slip method sequence to CSF, and develop temporal sequences with up-date.In order to clarify how CSF moves within the ventricles in response to head movement, we attempted to optimize its MRI visualization.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Perform MRI on normal subjects and patients with spinal fluid circulation disorders to collect and analyze information on cerebrospinal fluid physiology.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Age between 20 and 80 years old at the time of obtaining consent.
(2) After receiving a thorough explanation of the study, the subject of the research has given his/her free and voluntary written consent based on a thorough understanding of the study.

Key exclusion criteria

Those who generally cannot undergo MRI
(1) Patients with claustrophobia
(2) Those who cannot maintain rest in the MRI machine
(3) Those who will have magnetic metals inserted into the body
(iv) Those who have a pacemaker or other device inserted in the body
(5) Other subjects who are deemed inappropriate as research subjects by the principal investigator.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name MADOKA
Middle name
Last name NAKAJIMA

Organization

Juntendo University

Division name

Neurosurgery

Zip code

113-8342

Address

2-1-1, hongo, Bunkyo-ku, Tokyo

TEL

0338133111

Email

madoka66@juntendo.ac.jp


Public contact

Name of contact person

1st name MADOKA
Middle name
Last name NAKAJIMA

Organization

Juntendo University

Division name

Neurosurgery

Zip code

113-8342

Address

2-1-1, hongo, Bunkyo-ku, Tokyo

TEL

0338133111

Homepage URL


Email

madoka66@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name



Funding Source

Organization

National Science Foundation

Organization

Division

Category of Funding Organization

Government offices of other countries

Nationality of Funding Organization

United States of America


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Committee Faculty of Medicine, Juntendo University

Address

3-1-3, Hongo, Bunkyo-ku, Tokyo

Tel

03-5802-1584

Email

hongo-rinri@juntendo.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

H19-0002

Org. issuing International ID_1

Juntendo University

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

順天堂大学病院付属順天堂医院


Other administrative information

Date of disclosure of the study information

2023 Year 11 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 03 Month 31 Day

Date of IRB

2020 Year 04 Month 14 Day

Anticipated trial start date

2020 Year 06 Month 01 Day

Last follow-up date

2024 Year 10 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 11 Month 28 Day

Last modified on

2023 Year 11 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060389


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name